Clicky

Prothena Corporation plc(0PT) News

Date Title
May 29 Citizens JMP Slashes Prothena (PRTA) to $29 from $78 After AFFIRM-AL Trial Fails
May 28 Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform
May 27 Update: Prothena Shares Fall, Stock Downgraded by Multiple Research Firms After Birtamimab Development Discontinued
May 27 Jefferies Downgrades Prothena Corporation (PRTA) After Negative Trial Results
May 27 Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down
May 27 Biogen strikes RNAi deal with City; Aurion withdraws IPO
May 27 Why Is Prothena Stock Trading Lower On Tuesday?
May 26 Prothena’s Phase III trial for AL amyloidosis treatment misses endpoint
Feb 22 Prothena Full Year 2024 Earnings: Misses Expectations
Feb 21 Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus
Feb 21 Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...
Feb 20 Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates
Feb 20 Prothena: Q4 Earnings Snapshot
Feb 20 Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
Feb 4 Further weakness as Prothena (NASDAQ:PRTA) drops 16% this week, taking three-year losses to 61%
Dec 30 Prothena Announces Board of Directors Update